中国药学(英文版)2024,Vol.33Issue(5) :396-411.DOI:10.5246/jcps.2024.05.030

基于细胞衰老角度结直肠癌治疗方法的进展:中西药物的比较研究

Advancements in cellular senescence-based therapeutic approaches for colorectal cancer:a comparative study of Chinese and western medications

张涛 刘皓辰 赵亮 张沂婧 邓宇 何永恒
中国药学(英文版)2024,Vol.33Issue(5) :396-411.DOI:10.5246/jcps.2024.05.030

基于细胞衰老角度结直肠癌治疗方法的进展:中西药物的比较研究

Advancements in cellular senescence-based therapeutic approaches for colorectal cancer:a comparative study of Chinese and western medications

张涛 1刘皓辰 1赵亮 2张沂婧 1邓宇 1何永恒2
扫码查看

作者信息

  • 1. 湖南中医药大学研究生院,湖南长沙 410208
  • 2. 湖南省中医药研究院附属医院,湖南长沙 410006
  • 折叠

摘要

结直肠癌(Colorectal cancer,CRC)为临床高发的恶性肿瘤.本病由各种综合因素促成,病因病机复杂,至今尚未明确.细胞衰老是一种永久性的细胞周期终止状态,抗肿瘤发生有力的保护机制,在CRC发生中的发挥着至关重要的作用.CRC是一种发病率很高的恶性肿瘤,病因复杂且不甚明了.细胞衰老的特点是不可逆的细胞分裂停滞,它在CRC的发展过程中发挥着至关重要的作用,是防止肿瘤形成的一种防御机制.目前临床上治疗CRC的方法,如手术、放疗和化疗,往往副作用大、费用高,给患者带来巨大的生理和心理负担.因此,探究副反应轻且疗效稳定的中医药疗法迫在眉睫.近年来,大量相关研究表明中药单体及复方能调控癌细胞衰老而发挥抗癌的作用,为临床上防治CRC提供了新思路.然而,目前尚缺乏中医药调控细胞衰老防治CRC的系统综述.因此,本文对近年来靶向调节细胞衰老以治疗CRC的西药化合物、中药单体及复方进行系统总结,以期为CRC的治疗及药物研发提供新思路.

Abstract

Colorectal cancer(CRC)is a prevalent malignant neoplasm with complex and poorly understood etiology.Cellular senescence,characterized by irreversible cell division arrest,plays a crucial role in the development of CRC by acting as a defense mechanism against tumor formation.Current clinical treatment modalities for CRC,such as surgery,radiotherapy,and chemotherapy,often come with significant side effects and high costs,placing a substantial physical and psychological burden on patients.Consequently,exploring Chinese medicinal treatments with milder side effects and consistent efficacy is essential.Recent research has highlighted the potential of traditional Chinese medicine(TCM)components and formulations to modulate the senescence process of cancer cells and exhibit anticancer properties.These findings offer a promising avenue for the prevention and treatment of CRC within clinical settings.However,a comprehensive evaluation of how TCM can control cellular senescence to prevent and manage CRC is currently lacking.This article aims to provide a comprehensive overview of pharmaceutical compounds from western medicine,individual components of TCM,and their combinations in recent research that target cellular senescence as part of CRC treatment.The objective is to present new perspectives on CRC treatment and drug development.

关键词

细胞衰老/结直肠癌/中医药/西药/研究进展

Key words

Cellular senescence/Colorectal cancer/Traditional Chinese medicine/Western medicine/Research progress

引用本文复制引用

基金项目

Hunan Provincial Natural Science Foundation Facial Project(2021JJ30419)

Hunan Provincial Key Project of Chinese Medicine Research Program(2021017)

Changsha Science and Technology Bureau Key Project(kh2201062)

Hunan University of Chinese Medicine Postgraduate Innovation Project(2022CX45)

Health Commission of Hunan Province 2023 Health Appropriate Technology Promotion Program(202319019186)

出版年

2024
中国药学(英文版)
中国药学会

中国药学(英文版)

CSTPCDCSCD
影响因子:0.534
ISSN:1003-1057
参考文献量3
段落导航相关论文